FDA Unveils Adverse Event Reporting Rules For Combination Products
This article was originally published in The Gray Sheet
Executive Summary
FDA says its proposed adverse event reporting requirements for combination products will help manufacturers navigate the intricate array of reporting requirements for deaths and injuries